Related references
Note: Only part of the references are listed.Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2
Xiaojian Ni et al.
CANCER SCIENCE (2014)
Expression of miR-106b-25 induced by salvianolic acid B inhibits epithelial-to-mesenchymal transition in HK-2 cells
Qiong Tang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
An investigation into anti-proliferative effects of microRNAs encoded by the miR-106a-363 cluster on human carcinoma cells and keratinocytes using microarray profiling of miRNA transcriptomes
Cuong Khuu et al.
FRONTIERS IN GENETICS (2014)
Fibronectin induces MMP2 expression in human prostate cancer cells
Andrei Moroz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration
Angela Ogden et al.
CANCER AND METASTASIS REVIEWS (2013)
The role of RhoC in ovarian epithelial carcinoma: A marker for carcinogenesis, progression, prognosis, and target therapy
Yang Zhao et al.
GYNECOLOGIC ONCOLOGY (2013)
De-Regulated MicroRNAs in Pediatric Cancer Stem Cells Target Pathways Involved in Cell Proliferation, Cell Cycle and Development
Patricia C. Sanchez-Diaz et al.
PLOS ONE (2013)
MicroRNAs and the cell cycle
Maria Jose Bueno et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer
Kyung Sook Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Shielding the messenger (RNA): microRNA-based anticancer therapies
Elena Sotillo et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9
Yang Zhao et al.
GYNECOLOGIC ONCOLOGY (2010)
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation
Deepa Sampath et al.
BLOOD (2009)
The role of RhoC in growth and metastatic capacity of melanoma
Barbara Boone et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
RhoC Expression and Head and Neck Cancer Metastasis
Mozaffarul Islam et al.
MOLECULAR CANCER RESEARCH (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma
Hideyuki Abe et al.
BIOMEDICAL RESEARCH-TOKYO (2008)
Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer
Stefan Ambs et al.
CANCER RESEARCH (2008)
Mechanisms of microRNA deregulation in human cancer
Shan Deng et al.
CELL CYCLE (2008)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
RhoC is essential for the metastasis of gastric cancer
Na Liu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck
Celina G. Kleer et al.
CLINICAL CANCER RESEARCH (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Extracellular matrix remodelling: the role of matrix metalloproteinases
I Stamenkovic
JOURNAL OF PATHOLOGY (2003)
MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing
V Ambros
CELL (2003)
Share Paper
